ストックスクリーナーアプリを入手
8.69
0.81%
0.07
アフターアワーズ：
8.69
Regenxbio Inc (RGNX) 最新ニュース
Diabetic Retinopathy Pipeline Set for Transformational Breakthroughs by 2026 with 55+ Therapies expanding Clinical Innovation from Kodiak Sciences, Regenxbio, Adverum Biotechnologies | DelveInsight - Barchart.com
Diabetic Retinopathy Pipeline Set for Transformational - openPR.com
Regenxbio files $300M mixed shelf offering - MSN
REGENXBIO announces royalty monetization agreement for up to $250M - MSN
REGENXBIO Inc. (NASDAQ:RGNX) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Regenxbio's DB-OTO Gene Therapy Approved for Genetic Hearing Los - GuruFocus
Sarepta Loses Bid to Rehear Regenxbio DNA Patent Case Decision - Bloomberg Law News
(RGNX) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
RGNX (REGENXBIO Inc.) reports wider than expected Q4 2025 loss while shares climb on positive investor sentiment.Market Hype Signals - Xã Thanh Hà
Full Fed. Circ. Passes On Sarepta's Patent Rehearing Bid - Law360
REGENXBIO credits administrative team for ongoing operational success - Traders Union
REGENXBIO (NASDAQ:RGNX) Shares Pass Below 200-Day Moving AverageShould You Sell? - MarketBeat
REGENXBIO prioritizes patient access by strengthening commercial leadership - Traders Union
Lifshitz Law Firm Investigating PayPal, Enphase Energy, and REGENXBIO - National Today
RGNX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Stockholders of REGENXBIO Inc. to Contact the Firm Today! - ACCESS Newswire
RGNX DEADLINEFINAL REMINDER: Bronstein, Gewirtz & Grossman LLC Alerts REGENXBIO Inc. Investors to Participate in the Class Action Lawsuit Today - ACCESS Newswire
RGNX Deadline Today: RGRX Investors Have Opportunity to Lead REGENXBIO, Inc. Securities Fraud Lawsuit - The Malaysian Reserve
REGENXBIO Inc. Sued for Securities Law ViolationsContact the DJS Law Group to Discuss Your Rights - Benzinga
[ARS] REGENXBIO Inc. SEC Filing - Stock Titan
REGENXBIO (RGNX) 2026 proxy details director votes, auditor, and stock option exchanges - Stock Titan
RGNX Deadline Today: RGRX Investors Have Opportunity to Lead REG - GuruFocus
User - The Chronicle-Journal
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in AMC Entertainment Holdings, Inc. of Class Action Lawsuit and Upcoming Deadlines – AMC; APE - GlobeNewswire Inc.
REGENXBIO to Host Conference Call on March 5 to Discuss Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights - Eastern Progress
RGNX Deadline Today: Rosen Law Firm Urges REGENXBIO, Inc. (NASDAQ: RGNX) Stockholders with Large Losses to Contact the Firm for Information About Their Rights - The Joplin Globe
CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds REGENXBIO (RGNX) Investors of the Securities Class Action Lawsuit Deadline on April 14, 2026 - 巴士的報
RGNX Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in REGENXBIO Inc. Securities Lawsuit — The Gross Law Firm - Morningstar
REGENXBIO DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages REGENXBIO, Inc. Investors With Losses in Excess of $100K to Secure Counsel Before Important April 14 Deadline in Securities Class ActionRGNX - ACCESS Newswire
Levi & Korsinsky, LLP: RGNX Disclosure Timeline Reveals Pattern of Alleged Investor Harm - GlobeNewswire
Bronstein, Gewirtz & Grossman LLC Urges REGENXBIO Inc. Investors to Act: Class Action Filed Alleging Investor Harm - GlobeNewswire
RGNX Investors Have Opportunity to Lead REGENXBIO Inc. Securities Fraud Lawsuit with the Schall Law Firm - GlobeNewswire
Rosen Law Firm Encourages REGENXBIO Investors to Secure Counsel Before Deadline - National Today
REGENXBIO DEADLINE: ROSEN, A LEADING AND RANKED FIRM, Encourages REGENXBIO, Inc. Investors with ... - Bluefield Daily Telegraph
REGENXBIO DEADLINE: ROSEN, A LEADING AND RANKED FIRM, - GlobeNewswire
How (RGNX) Movements Inform Risk Allocation Models - Stock Traders Daily
REGENXBIO DEADLINE: ROSEN, A LEADING, LONGSTANDING, AND TOP RANKED FIRM, Encourages REGENXBIO, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important April 14 Deadline in Securities Class ActionRGNX - ACCESS Newswire
REGENXBIO DEADLINE: ROSEN, A LEADING NATIONAL FIRM, Encourages REGENXBIO, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important April 14 Deadline in Securities Class ActionRGNX - TMX Newsfile
RGNX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Shareholders of REGENXBIO Inc. to Contact the Firm Today! - ACCESS Newswire
Portfolio Shifts: How is REGENXBIO Inc managing supply chain issues2026 Sentiment & High Conviction Investment Ideas - baoquankhu1.vn
RGNX Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in REGENXBIO ... - Bluefield Daily Telegraph
RGNX Shareholder Alert: Investors With Losses May Seek to - GlobeNewswire
RGNX UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds REGENXBIO (RGNX) Investors of Securities Class Action Deadline on April 14, 2026 - ChartMill
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages REGENXBIO, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class ActionRGNX - wahanariau.com
Press releases provided by CNW - Techaeris
RGNX Investors Have Opportunity to Lead REGENXBIO, Inc. Securities Fraud Lawsuit - GuruFocus
Institution Moves: Is REGENXBIO Inc stock showing strong momentumOil Prices & Safe Entry Zone Identification - baoquankhu1.vn
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in REGENXBIO Inc. of Class Action Lawsuit and Upcoming DeadlinesRGNX - PR Newswire
RGNX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Investors of REGENXBIO Inc. to Contact the Firm Today! - ACCESS Newswire
Lead Plaintiff Deadlines in Shareholder Class Action - GlobeNewswire
RGNX Stockholders Have Opportunity to Lead REGENXBIO Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in REGENXBIO Inc. of Class Action Lawsuit and Upcoming Deadlines – RGNX - FinancialContent
RGNX Shareholder Alert: April 14, 2026 Lead Plaintiff Deadline i - GuruFocus
RGNX Shareholders Have Opportunity to Lead REGENXBIO Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - ACCESS Newswire
RGNX Shareholder Alert: April 14, 2026 Lead Plaintiff Deadline in REGENXBIO Inc. Securities Class Action Lawsuit -- The Gross Law Firm - Barchart.com
Portnoy Law Firm Announces Class Action on Behalf of REGENXBIO, Inc. Investors - GlobeNewswire
Book value per share of REGENXBIO, Inc. – SWB:RB0 - TradingView — Track All Markets
0.29%
0.00%
大文字化:
|
ボリューム (24 時間):